Qingyi Wei



  1. Jia M, Xu Y, Zhu M, Wang M, Sun M, Qian J, et al. The P38? rs3804451 Variant Predicts Chemotherapy Response and Survival of Patients with Non-Small Cell Lung Cancer Treated with Platinum-Based Chemotherapy. Transl Oncol. 2016;9:531-539 pubmed publisher
    ..Larger studies of additional patient populations are needed to validate our findings. ..
  2. Shi T, Jiang Z, Jiang R, Yin S, Wang M, Yu K, et al. Polymorphisms in the kinesin-like factor 1 B gene and risk of epithelial ovarian cancer in Eastern Chinese women. Tumour Biol. 2015;36:6919-27 pubmed publisher
    ..Taken together, the rs17401966 polymorphism likely regulates KIF1B mRNA expression and thus may be associated with EOC risk in Eastern Chinese women. Larger, independent studies are warranted to validate our findings. ..
  3. Zhang R, Jia M, Xue H, Xu Y, Wang M, Zhu M, et al. Genetic variants in ERCC1 and XPC predict survival outcome of non-small cell lung cancer patients treated with platinum-based therapy. Sci Rep. 2017;7:10702 pubmed publisher
    ..Larger studies are needed to validate our findings with further functional studies to elucidate the mechanisms underlying these observed associations. ..
  4. Bai Y, Xu L, Yang X, Hu Z, Yuan J, Wang F, et al. Sequence variations in DNA repair gene XPC is associated with lung cancer risk in a Chinese population: a case-control study. BMC Cancer. 2007;7:81 pubmed
    ..However, these findings need to be verified in larger confirmatory studies with more comprehensively selected tagging SNPs. ..